Novozymes A/S
CSE:NZYM B
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
346.4
419.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Novozymes A/S
Net Margin
Novozymes A/S
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | DK |
| Market Cap | 165.6B DKK |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 99.8B USD |
| Net Margin |
11%
|
| Country | JP |
| Market Cap | 11.2T JPY |
| Net Margin |
21%
|
| Country | US |
| Market Cap | 70.4B USD |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 35.8B CHF |
| Net Margin |
15%
|
| Country | US |
| Market Cap | 35B USD |
| Net Margin |
7%
|
| Country | CN |
| Market Cap | 230.5B CNY |
| Net Margin |
8%
|
| Country | CH |
| Market Cap | 27.9B EUR |
| Net Margin |
20%
|
| Country | US |
| Market Cap | 28.6B USD |
| Net Margin |
8%
|
| Country | IN |
| Market Cap | 2.4T INR |
| Net Margin |
14%
|
| Country | US |
| Market Cap | 23.3B USD |
| Net Margin |
-20%
|
Novozymes A/S
Glance View
Novozymes A/S is a global leader in biotechnology, focusing on the production of enzymes and microorganisms that enhance industrial processes. Founded in 1925 and based in Denmark, the company has consistently leveraged its deep scientific expertise to innovate solutions across various sectors, including agriculture, bioenergy, and food & beverage. By developing sustainable alternatives to traditional chemical processes, Novozymes not only improves efficiency for its clients but also helps minimize environmental impact. As industries continue to shift towards greener practices, Novozymes stands at the forefront of this transition, positioning itself as a pivotal player committed to driving sustainable development. For investors, Novozymes represents a compelling opportunity in a growing market driven by increasing awareness of sustainability and resource efficiency. The company boasts a diverse portfolio of products and a strong track record of profitability, sustained by its continuous investment in research and development. With a robust customer base spanning across more than 30 industries, Novozymes is well-equipped to capitalize on the expanding demand for bio-based solutions. Investors can find confidence in Novozymes' strategic focus on innovation and its ability to adapt to the evolving landscape of global sustainability goals, making it a strong candidate for those looking to invest in a future-oriented enterprise.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Novozymes A/S's most recent financial statements, the company has Net Margin of 16.9%.
You don't have any saved screeners yet
